Net Worth Advisory Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$816K Buy
7,634
+351
+5% +$33.9K 0.21% 125
2026
Q2
$570K Sell
7,283
-190
-3% -$13K 0.14% 165
2026
Q1
$483K Buy
7,473
+656
+10% +$46.2K 0.1% 207
2025
Q4
$459K Buy
6,817
+1,062
+18% +$71.4K 0.09% 223
2025
Q3
$422K Sell
5,755
-297
-5% -$19.7K 0.12% 190
2025
Q2
$315K Buy
6,052
+426
+8% +$24.2K 0.07% 288
2025
Q1
$359K Sell
5,626
-52
-0.9% -$3.02K 0.11% 208
2024
Q4
$271K Sell
5,678
-42
-0.7% -$2.15K 0.08% 278
2024
Q3
$327K Buy
+5,720
New +$328K 0.1% 245

Other funds holding HALO

Net Worth Advisory Group's HALO Position: Q3 2026 in Review

Net Worth Advisory Group increased its Halozyme (HALO) stake by 4.8% in Q3 2026, buying an estimated $33.9K and bringing the position to 7,634 shares worth $816K. The position accounts for 0.21% of the portfolio, ranked #125.

Net Worth Advisory Group first reported a position in HALO in Q3 2024 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Net Worth Advisory Group held 7,634 shares of Halozyme worth $816K as of Q3 2026.
  • Net Worth Advisory Group bought 351 Halozyme shares in Q3 2026, an estimated $33.9K.
  • Halozyme made up 0.21% of Net Worth Advisory Group's portfolio in Q3 2026, its #125 holding.
  • Net Worth Advisory Group first reported a position in Halozyme in Q3 2024 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Net Worth Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.